Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Okawa

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Leukemia|April 17, 2009
Ascorbic acid inhibits antitumor activity of bortezomib in vivoG Perrone, T Hideshima, H Ikeda, et al.
Leukemia|February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathwayH Yasui, T Hideshima, H Ikeda, et al.
Oncogene|January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibitionL Santo, S Vallet, T Hideshima, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Leukemia|April 17, 2009
Ascorbic acid inhibits antitumor activity of bortezomib in vivoG Perrone, T Hideshima, H Ikeda, et al.
Leukemia|February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathwayH Yasui, T Hideshima, H Ikeda, et al.
Oncogene|January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibitionL Santo, S Vallet, T Hideshima, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Pageof 9